For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions
-
June 15, 2026
-
0 min
Clinical Report: Lifestyle Changes Reduce the Risk of Multiple Chronic Conditions
Overview
A long-term NIH-supported clinical trial found that lifestyle interventions significantly reduced the risk of developing multiple chronic conditions in adults with prediabetes compared to placebo. In contrast, metformin did not show a statistically significant benefit in reducing multimorbidity risk.
Background
Multimorbidity is a prevalent issue that complicates healthcare management and increases the burden on health systems. Effective interventions to prevent or delay the onset of multiple chronic conditions are crucial, especially for individuals with prediabetes, who are at heightened risk for developing diabetes and other chronic diseases. This study underscores the importance of lifestyle modifications in improving long-term health outcomes.
Data Highlights
| Group | Risk Reduction for 2 Conditions | Risk Reduction for 3 Conditions |
|---|---|---|
| Lifestyle | 21% | 25% |
| Metformin | No significant reduction | No significant reduction |
| Placebo | Reference | Reference |
Key Findings
- Lifestyle intervention participants had a 21% lower risk of developing two chronic conditions compared to placebo.
- Participants in the lifestyle group had a 25% lower risk of developing three chronic conditions compared to placebo.
- 82%, 85%, and 87% of participants in the lifestyle, metformin, and placebo groups, respectively, experienced multimorbidity.
- Metformin did not result in a statistically significant reduction in multimorbidity risk.
- The study tracked 15 chronic conditions, including hypertension, heart disease, and diabetes.
- Findings suggest that lifestyle modifications can persistently lower the risk of developing multiple chronic conditions beyond diabetes.
Clinical Implications
Healthcare providers should prioritize lifestyle interventions for patients with prediabetes to mitigate the risk of multimorbidity. Given the lack of significant benefits from metformin in this context, lifestyle changes should be emphasized as a primary strategy for prevention.
Conclusion
The findings from this study highlight the critical role of lifestyle interventions in reducing the risk of multiple chronic conditions in adults with prediabetes. This approach may lead to improved health outcomes and reduced healthcare costs.
Related Resources & Content
- NIH, JAMA, 2026 -- Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes
- American Diabetes Association, Diabetes Care, 2026 -- Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2026
- conexiant — Healthy Lifestyle Lowers Cardiometabolic Risk in Hypertension
- The Journal of Clinical Endocrinology & Metabolism — Emerging Strategies for Preventing Type 2 Diabetes
- The Journal of Clinical Endocrinology & Metabolism — Subclassification of Prediabetes, Associated Type 2 Diabetes Risk, and Varied Impact of Preventive Strategies
- The Journal of Clinical Endocrinology & Metabolism — Creation and Assessment of a Personalized Diabetes Risk Prediction Model Incorporating Tailored Preventive Intervention Outcomes
- Healthy Lifestyle Lowers Cardiometabolic Risk in Hypertension
- Emerging Strategies for Preventing Type 2 Diabetes
- Subclassification of Prediabetes, Associated Type 2 Diabetes Risk, and Varied Impact of Preventive Strategies
- Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes
- 3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
- Tirzepatide for Obesity Treatment and Diabetes Prevention | New England Journal of Medicine
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.